Nancy E Davidson
机构: Fred Hutchinson Cancer Research Center
每年引用次数
引用次数
引用: 104,633
H-指数: 132
I10-指数 : 404
出版物: 725
Investigating genetic drivers of disease progression in invasive lobular carcinoma
Nilgun Tasdemir , Matthew Sikora , Li Zhu , Kevin Levine
Molecular Cancer Research 16 ( 8) 89 -89
2018
Metastatic Breast Cancer: Tailored Endocrine Therapy for Premenopausal Women
Tatiana M. Prowell , Nancy E. Davidson
Breast Cancer and Molecular Medicine 451 -464
2006
Changes in Breast Density and Circulating Estrogens in Postmenopausal Women Receiving Adjuvant Anastrozole
Tatiana M. Prowell , Amanda L. Blackford , Celia Byrne , Nagi F. Khouri
Cancer Prevention Research 4 ( 12) 1993 -2001
21
2011
Low estrogen receptor (ER) positive breast cancer and neoadjuvant systemic therapy (NAT): Is response similar to ER+ or to ER- disease?
Alessandra Landmann , Daniel J. Farrugia , Emilia Diego , Atilla Soran
Journal of Clinical Oncology 34 580 -580
2016
HER2 equivocal breast cancer and neoadjuvant therapy: Is response similar to HER2-positive or HER2-negative tumors?
Alessandra Landmann , Daniel J. Farrugia , Emilia Diego , Marguerite Bonaventura
Journal of Clinical Oncology 34 612 -612
3
2016
Local Excision Alone Without Irradiation for Ductal Carcinoma In Situ of the Breast: A Trial of the Eastern Cooperative Oncology Group
Lorie L. Hughes , Molin Wang , David L. Page , Robert Gray
Journal of Clinical Oncology 27 ( 32) 5319 -5324
307
2009
Reply to J.M. Guinebretiere and L. Arnould et al
Sunil S. Badve , Frederick L. Baehner , Robert P. Gray , Barrett H. Childs
Journal of Clinical Oncology 27 ( 16) 2734 -2735
2009
Timed Sequential Treatment With Cyclophosphamide, Doxorubicin, and an Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Secreting Breast Tumor Vaccine: A Chemotherapy Dose-Ranging Factorial Study of Safety and Immune Activation
Leisha A. Emens , Justin M. Asquith , James M. Leatherman , Barry J. Kobrin
Journal of Clinical Oncology 27 ( 35) 5911 -5918
236
2009
The importance of cytologic intrarater and interrater reproducibility: the case of ductal lavage.
Kala Visvanathan , Deborah Santor , Syed Z. Ali , In Soon Hong
Cancer Epidemiology, Biomarkers & Prevention 15 ( 12) 2553 -2556
5
2006
Impact of adjuvant trastuzumab on locoregional failure rates in a randomized clinical trial: North Central Cancer Treatment Group N9831 (alliance) study.
Carlos E. Vargas , Cameron S. Thorpe , Amylou C. Dueck , Kathleen S. Tenner
Cancer 126 ( 24) 5239 -5246
2020
How we maintain bone health in early-stage breast cancer patients on aromatase inhibitors.
Ting Bao , Nancy E. Davidson
Journal of Oncology Practice 3 ( 6) 323 -325
2
2007
Soluble human epidermal growth factor receptor 2 (HER2) levels in patients with HER2-positive breast cancer receiving chemotherapy with or without trastuzumab: Results from North Central Cancer Treatment Group adjuvant trial N9831
Alvaro Moreno-Aspitia , David W. Hillman , Stephen H. Dyar , Kathleen S. Tenner
Cancer 119 ( 15) 2675 -2682
32
2013
Still Waiting After 110 Years: The Optimal Use of Ovarian Ablation As Adjuvant Therapy for Breast Cancer
Antonio C. Wolff , Nancy E. Davidson
Journal of Clinical Oncology 24 ( 31) 4949 -4951
7
2006
American Society of Clinical Oncology 2006 Update of the Breast Cancer Follow-Up and Management Guidelines in the Adjuvant Setting
James L. Khatcheressian , Antonio C. Wolff , Thomas J. Smith , Eva Grunfeld
Journal of Clinical Oncology 24 ( 31) 5091 -5097
632
2006
Efficacy of Letrozole Extended Adjuvant Therapy According to Estrogen Receptor and Progesterone Receptor Status of the Primary Tumor: National Cancer Institute of Canada Clinical Trials Group MA.17
Paul E. Goss , James N. Ingle , Silvana Martino , Nicholas J. Robert
Journal of Clinical Oncology 25 ( 15) 2006 -2011
119
2007
Myeloid Toxicity in Breast Cancer Patients Receiving Adjuvant Chemotherapy With Pegfilgrastim Support
Antonio C. Wolff , Richard J. Jones , Nancy E. Davidson , Stacie C. Jeter
Journal of Clinical Oncology 24 ( 15) 2392 -2394
16
2006
American Society of Clinical Oncology 1998 Update of Recommended Breast Cancer Surveillance Guidelines
Thomas J. Smith , Nancy E. Davidson , David V. Schapira , Eva Grunfeld
Journal of Clinical Oncology 17 ( 3) 1080 -1082
224
1999
Road Map to Safe and Well-Designed De-escalation Trials of Systemic Adjuvant Therapy for Solid Tumors.
Martine J. Piccart , Florentine S. Hilbers , Judith M. Bliss , Carmela Caballero
Journal of Clinical Oncology 38 ( 34) 4120 -4129
22
2020
A feasibility study of cyclophosphamide, trastuzumab, and an allogeneic GM-CSF-secreting breast tumor vaccine for HER2+ metastatic breast cancer.
Gang Chen , Richa Gupta , Silvia Petrik , Marina Laiko
Cancer immunology research 2 ( 10) 949 -961
79
2014
HER2 and Chromosome 17 Effect on Patient Outcome in the N9831 Adjuvant Trastuzumab Trial
Edith A. Perez , Monica M. Reinholz , David W. Hillman , Kathleen S. Tenner
Journal of Clinical Oncology 28 ( 28) 4307 -4315
177
2010